| Application no. and date | 12747134.0 (espacenet) (Federated) (European Patent Register), 20120217 | | Patent/reg. no. and date | DK/EP 2675893, 20190109 | | Publication date | 20131225 | | Priority no. and date | US 201161444666 P, 20110218 | | EP pub. no. and date |
EP 2675893 20131225 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH,
The Scripps Research Institute, Mail Drop TPC-8
10550 North Torrey Pines Road
La Jolla, CA 92037, US | | Applicant ref. no. | P81901365DK00E | | Inventor | SCHULTZ, Peter, 1650 La Jolla Rancho Road
La Jolla
California 92037, US,
DESHMUKH, Vishal, 8771 Gilman Drive, Apt. A
La Jolla
California 92037, US,
LYSSIOTIS, Costas, 231 Park Drive, Apt. 38
Boston
Massachusetts 02215, US,
LAIRSON, Luke, 2771 North Arroyo Drive
San Diego
California 92103, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | C12N 5/00 (2006.01) | | Title | Dirigeret differentiering af oligodendrocyt-præcursorceller til en myeliniseringscelleskæbne | | Int. application no. | US2012025712 | | Int. publication no. | WO2012112933 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
